Several studies have established the prognostic value of vasodilator stress CMR in broad population of patients with suspected or known coronary artery disease (CAD), but this specific population of asymptomatic patients with known CAD have never been formally evaluated. Therefore, this study aimed to assess the long-term prognostic value of vasodilator stress perfusion cardiovascular magnetic resonance (CMR) in asymptomatic patients with obstructive CAD.
What is the current state/problem in practice? The assessment of the prognostic value of vasodilator stress CMR in asymptomatic patients with known CAD have never been formally evaluated. While risk stratification of asymptomatic patients can be useful in managing secondary prevention, the European and American guidelines do not recommend systematic stress testing in the follow-up of patients with CAD, because they are mainly based on studies of symptomatic patients. What is the ideal state/ if the problem is gone? An improved risk stratification using stress CMR in asymptomatic patients with known CAD could allow to identify high-risk patients who could benefit from treatment intensification, new therapy and/or revascularization.
Knowing that in asymptomatic patients with known CAD, the presence of inducible myocardial ischemia and LGE assessed by stress CMR could be helpful to stratify the risk of CV events recurrence.
?To close the gap outlined above:
- Learners need to know about (knowledge): the prognostic value of stress CMR in asymptomatic patients with known CAD
- Learners need to know how to apply (intention to put into practice): the interest of the detection of the presence of inducible myocardial ischemia and LGE assessed by stress CMR to stratify the risk of CV events recurrence.
- Learners need to do (perform): to analyze images perfusion and LGE to detect the presence of inducible myocardial ischemia and LGE.
The Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The Society for Cardiovascular Magnetic Resonance (SCMR) designates this Journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions for Claiming CME
- Read and fully comprehend the article
- Complete the post-activity evaluation
- A certificate of completion will be available once the evaluation is submitted
Disclosure of Commercial Support
The planners and faculty for this activity did not have any relationships to disclose.
1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019 05;139(10):e56–528. 2. Krumholz HM, Normand S-LT, Wang Y. Twenty-Year Trends in Outcomes for Older Adults With Acute Myocardial Infarction in the United States. JAMA Netw Open. 2019 01;2(3):e191938. 3. Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O’Brien SM, Boden WE, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020 09;382(15):1395–407. 4. Anand DV, Lim E, Raval U, Lipkin D, Lahiri A. Prevalence of silent myocardial ischemia in asymptomatic individuals with subclinical atherosclerosis detected by electron beam tomography. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2004;11(4):450–7. 5. Biagini E, Schinkel AFL, Bax JJ, Rizzello V, van Domburg RT, Krenning BJ, et al. Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography. Heart Br Card Soc. 2005;91(6):737–42. 6. Deedwania PC, Carbajal EV. Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation. 1990;81(3):748–56. 7. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003;107(1):149–58. 8. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020 14;41(3):407–77. 9. Heitner JF, Kim RJ, Kim HW, Klem I, Shah DJ, Debs D, et al. Prognostic Value of Vasodilator Stress Cardiac Magnetic Resonance Imaging: A Multicenter Study With 48?000 Patient-Years of Follow-up. JAMA Cardiol. 2019 01;4(3):256–64. 10. Kwong RY, Ge Y, Steel K, Bingham S, Abdullah S, Fujikura K, et al. Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain. J Am Coll Cardiol. 2019;74(14):1741–55. 11. Nagel E, Greenwood JP, McCann GP, Bettencourt N, Shah AM, Hussain ST, et al. Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease. N Engl J Med. 2019;380(25):2418–28. 12. Bodi V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L, Monmeneu JV, et al. Prognostic and therapeutic implications of dipyridamole stress cardiovascular magnetic resonance on the basis of the ischaemic cascade. Heart Br Card Soc. 2009;95(1):49–55. 13. Vincenti G, Masci PG, Monney P, Rutz T, Hugelshofer S, Gaxherri M, et al. Stress Perfusion CMR in Patients With Known and Suspected CAD. JACC Cardiovasc Imaging. 2017;10(5):526–37. 14. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018 30;72(18):2231–64. 15. Hicks KA, Tcheng JE, Bozkurt B, Chaitman BR, Cutlip DE, Farb A, et al. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials. J Am Coll Cardiol. 2015;66(4):403–69. 16. Stone GW, Ben-Yehuda O, Sabik JF, Kappetein AP, Serruys PW. Considerations for an optimal definition of procedural myocardial infarction. Eur Heart J. 2020;41(17):1704–5. 17. Pezel T, Sanguineti F, Kinnel M, Hovasse T, Garot P, Unterseeh T, et al. Prognostic value of dipyridamole stress perfusion cardiovascular magnetic resonance in elderly patients >75 years with suspected coronary artery disease. Eur Heart J Cardiovasc Imaging. 2020; 18. Kinnel M, Garot J, Pezel T, Hovasse T, Unterseeh T, Champagne S, et al. Prognostic Value of Vasodilator Stress Perfusion CMR in Morbidly Obese Patients (BMI ≥40 kg/m2) Without Known CAD. JACC Cardiovasc Imaging. 2020;13(5):1